D. A. Butterfield

Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.

D. Butterfield, R. Sultana, W. Pierce, 2009, Journal of proteome research.

Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age.

Jian Cai, D. Butterfield, R. Sultana, 2011, Journal of proteomics.

Redox proteomics in some age-related neurodegenerative disorders or models thereof

D. Butterfield, H. Abdul, Tanea T Reed, 2006, NeuroRX.

Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics.

D. Butterfield, R. Sultana, M. Perluigi, 2006, Antioxidants & redox signaling.

Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.

D. Butterfield, R. Sultana, D. Boyd-Kimball, 2004, Chemical research in toxicology.

mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy

D. Butterfield, F. Di Domenico, M. Perluigi, 2015, Neurobiology of Disease.

Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder.

D. Butterfield, R. Sultana, D. A. Butterfield, 2007 .

The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation

D. Butterfield, C. Mancuso, E. Barone, 2014, Neurobiology of Disease.